% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@PHDTHESIS{Leubner:144863,
author = {Leubner, Jonas},
title = {{Z}ellbasierte {T}estverfahren zur {U}ntersuchung von
{NMDA}-{R}ezeptor-{A}ntikörpern},
school = {Charité Universitätsmedizin Berlin},
type = {Habilitationsschrift},
publisher = {Charité - Universitätsmedizin Berlin},
reportid = {DZNE-2020-00288},
pages = {20 pages},
year = {2017},
note = {Habilitationsschrift, Charité Universitätsmedizin Berlin,
2017},
abstract = {Discovered in 2007, anti-N-Methyl-D-Aspartat receptor
(NMDAR) encephalitis is one of the most commonly identified
causes for encephalitis. The disease often runs a severe and
rapid course showing reduced state of consciousness,
epileptic seizures, autonomic dysregulation and hypopnea
leading to intensive care unit treatment and even death.
Clinical diagnosis is made by detection of pathogenic NMDAR
antibodies from a patient’s cerebrospinal fluid (CSF) or
serum. Little is known about prognosis factors for the
disease severity, but would be helpful for providing early
and appropriate treatment. We suppose the affinity of NMDAR
antibodies might be an important predicting factor. We
developed highly sensitive methods to detect low
concentrations of NMDAR antibodies, which can be used to
analyze antibody affinity of different patients in future.
Therefore, cDNA of the NR1 subunit of the NMDA receptors was
amplified by polymerase chain reaction, cloned into
different vectors and purified from Escheria coli for
transient and stable transfection. Immunofluorescence
staining on transfected HEK-cells detected lower
concentrations of human NMDAR antibodies than commercial
assays and flow cytometry showed exact quantification of the
antibody titer, which can be used to monitor clinical
progress and evaluate therapeutic success in follow-up
examinations. Further CSF was conjugated with Alexa Fluor
594 to detect human and non-human NMDA receptor antibodies
without secondary antibodies. The post mortem CSF analysis
of a young polar bear (Ursus maritimus) suffering epileptic
seizures showed strong binding to HEK cells expressing NMDA
receptors. Tissue immunohistochemistry exploration
demonstrated a typical neuropil signal in hippocampus and
cerebellum as in human patients with NMDAR encephalitis and
histopathological examination showed an encephalitis with
infiltration of plasma cells. We conclude, death was caused
by NMDAR encephalitis. This is the first reported non-human
case and suggests, that other mammals might suffer from this
treatable disease. Autoimmune response against neuropil
structures might be a basic pathomechanism across mammal
species.},
keywords = {NMDA-receptor-encephalitis (Other) / NMDAR antibodies
(Other) / 600 Technik, Medizin, angewandte
Wissenschaften::610 Medizin und Gesundheit (Other)},
cin = {AG Prüß},
cid = {I:(DE-2719)1810003},
pnm = {342 - Disease Mechanisms and Model Systems (POF3-342)},
pid = {G:(DE-HGF)POF3-342},
typ = {PUB:(DE-HGF)13},
urn = {urn:nbn:de:kobv:188-fudissthesis000000105584-9},
doi = {10.17169/REFUBIUM-6306},
url = {https://pub.dzne.de/record/144863},
}